Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Fatin Fazrina Roslan , Yuexin Yu , Nurul Ain Nasim Mohd Yusof , et al Added: 1 year ago

Anticoagulation
Immune Cell Traits and Aortic Dissection: A Mendelian Randomisation Study
Author(s): Tian-le Li , Mao-long Fu , Li-hong Wang , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Inherited and Congenital Cardiac Conditions
Erratum: Causal Characteristics of Immune Cells
Author(s): Tian-le Li , Mao-long Fu , Li-hong Wang , et al Added: 1 year ago
MicroRNAs for Cardiac Regeneration
Author(s): Camilla Olianti , Mauro Giacca Added: 8 months ago

Prevention & Chronic Conditions

Heart Failure
30th Annual Meeting of the ISCP
Author(s): Maria Fernández García , Alberto Alen Andrés , Beatriz Nieves Ureña , et al Added: 1 month ago

Prevention & Chronic Conditions

CV Disease in Special Populations
30th Annual Meeting of the ISCP
Author(s): Diego Manuel de la Eranueva , Cristina Helguera Amezua , Adela Castro Garcia , et al Added: 1 month ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s): Wei Gao , Hui Wang , Jian-long Wang , et al Added: 7 months ago

Demographic

Heart Failure
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 1 year ago

CV Disease in Special Populations

Heart Failure
Job title: Physician